Findings of the research team were based on observations of enhanced medical complicacies after treatment in such patients. “Major surgical complications occurred in 11.5 percent of patients, and 11.6 percent experienced major medical complications”, said the research team. Some of these complicacies could ultimately lead to renal diseases like cancer, they also explained.
After carrying out an extensive research with around 224 patients that were administered rhBPM2, the researchers found that the occurrence of cancer in patients is around 3.37%. What raised their concerns is that the incidence rate was as high as 6.75 at only a couple of years and could go higher with further passage of time.
No comments:
Post a Comment